Reported Nov 22, 2017 · Terminated
Clolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use, Rx Only, Mfd. by: Teva Pharmachemie Swensweg…
Genzyme Corporation
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Genzyme Corporation · 11 Forbes Rd · Northborough, MA · 01532-2501
Is this the product you have?
- Clolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use, Rx Only, Mfd
- byTeva Pharmachemie Swensweg 5 Haarlem, The Netherlands Mfd
- forGenzyme Corporation, Cambridge, MA 02142, NDC 0024-5860-01
- Lot codes and dates
Lot #: K5006Y01Exp. 08/31/18 Lot #: K5006Y03Exp. 08/31/18 Lot #: K6001Y01Exp. 03/31/19
- Amount recalled
- 9,343 single dose vials
Where it was sold
- Nationwide
Why it was recalled
Labeling: Incorrect or Missing Package Insert.
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Genzyme Corporation recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.